{"id":536670,"date":"2021-09-09T16:18:05","date_gmt":"2021-09-09T20:18:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/"},"modified":"2021-09-09T16:18:05","modified_gmt":"2021-09-09T20:18:05","slug":"nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/","title":{"rendered":"Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021"},"content":{"rendered":"

<\/p>\n

Nanobiotix:\u00a0Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021<\/b><\/p>\n

In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorit\u00e9 des March\u00e9s Financiers (French Financial Markets Authority)<\/i><\/b><\/p>\n

PARIS–(BUSINESS WIRE<\/a>)–
\nRegulatory News:\n<\/p>\n

\nNanobiotix (Paris:NANO) (NASDAQ:NBTX):\n<\/p>\n

\nMarket: Euronext Paris
\n
Compartment: B
\n
ISIN code: FR0011341205
\n
Website: www.nanobiotix.com<\/a><\/p>\n\n\n\n\n
\n

Date<\/b><\/p>\n<\/td>\n

\n

Number of Shares<\/b><\/p>\n

Outstanding<\/b><\/p>\n<\/td>\n

\n

Total number of voting rights<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

Total voting rights, <\/b><\/p>\n

gross (1)<\/sup><\/b>\u00a0\n<\/p>\n<\/td>\n

\n

Total voting rights, <\/b><\/p>\n

net (2)<\/sup><\/b><\/p>\n<\/td>\n<\/tr>\n

\n

\nAugust 31, 2021\n<\/p>\n<\/td>\n

\n

\n34,825,872\n<\/p>\n<\/td>\n

\n

\n36,019,979\n<\/p>\n<\/td>\n

\n

\n36,010,846\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

(1)<\/sup> The total number of gross (or \u201ctheoretical\u201d) voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.<\/i><\/p>\n

(2)<\/sup> The total number of net (or \u201cexercisable at a Shareholders\u2019 Meeting\u201d) voting rights is calculated without taking into account shares for which voting rights have been suspended. It is released in order to ensure that the public is properly informed, in accordance with the AMF recommendation of July 17, 2007.<\/i><\/p>\n

***<\/i><\/p>\n

About NANOBIOTIX : <\/b>http:\/\/www.nanobiotix.com<\/a><\/p>\n

\nNanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity.\n<\/p>\n

\nThe company\u2019s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life. Incorporated in 2003, Nanobiotix is headquartered in Paris, France. The company also has subsidiaries in Cambridge, Massachusetts (United States), France, Spain, and Germany. Nanobiotix has been listed on Euronext: Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020.\n<\/p>\n

\nNanobiotix is the owner of more than 30 umbrella patents associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.\n<\/p>\n

\nThe company’s resources are primarily devoted to the development of its lead product candidate\u2013NBTXR3\u2014which is the product of its proprietary oncology platform and has already achieved market authorization in Europe for the treatment of patients with soft tissue sarcoma under the brand name Hensify\u00ae.\n<\/p>\n

\nFor more information about Nanobiotix, visit us at http:\/\/www.nanobiotix.com<\/a>or follow us on LinkedIn<\/a> and Twitter<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210909006044\/en\/<\/a><\/span><\/p>\n

Nanobiotix Communications
\n<\/b>
Brandon Owens
\n<\/i>
VP, Communications
\n<\/i>
+1 (617) 852-4835
\n
contact@nanobiotix.com <\/a><\/p>\n

Nanobiotix Investor Relations
\n<\/b>
Kate McNeil
\n<\/i>
SVP, Investor Relations
\n<\/i>
+1 (609) 678-7388
\n
investors@nanobiotix.com <\/a><\/p>\n

Media Relations<\/i><\/p>\n

\nFrance \u2013 Ulysse Communication
\n<\/b>
Pierre-Louis Germain
\n
+ 33 (0) 6 64 79 97 51
\n
plgermain@ulysse-communication.com<\/a><\/p>\n

\nUS \u2013 Porter Novelli
\n<\/b>
Dan Childs
\n
+1 (781) 888-5106
\n
dan.childs@porternovelli.com<\/a><\/p>\n

KEYWORDS:<\/b> Europe United States North America France New York<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Nanobiotix:\u00a0Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021 In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorit\u00e9 des March\u00e9s Financiers (French Financial Markets Authority) PARIS–(BUSINESS WIRE)– Regulatory News: Nanobiotix (Paris:NANO) (NASDAQ:NBTX): Market: Euronext Paris Compartment: B ISIN code: FR0011341205 Website: www.nanobiotix.com Date Number of Shares Outstanding Total number of voting rights Total voting rights, gross (1)\u00a0 Total voting rights, net (2) August 31, 2021 34,825,872 36,019,979 36,010,846 (1) The total number of gross (or \u201ctheoretical\u201d) voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated … <\/p>\n

Continue reading “Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-536670","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Nanobiotix:\u00a0Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021 In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorit\u00e9 des March\u00e9s Financiers (French Financial Markets Authority) PARIS–(BUSINESS WIRE)– Regulatory News: Nanobiotix (Paris:NANO) (NASDAQ:NBTX): Market: Euronext Paris Compartment: B ISIN code: FR0011341205 Website: www.nanobiotix.com Date Number of Shares Outstanding Total number of voting rights Total voting rights, gross (1)\u00a0 Total voting rights, net (2) August 31, 2021 34,825,872 36,019,979 36,010,846 (1) The total number of gross (or \u201ctheoretical\u201d) voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated … Continue reading "Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-09T20:18:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210909006044r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021\",\"datePublished\":\"2021-09-09T20:18:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\\\/\"},\"wordCount\":472,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210909006044r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\\\/\",\"name\":\"Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210909006044r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-09-09T20:18:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210909006044r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210909006044r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/","og_locale":"en_US","og_type":"article","og_title":"Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021 - Market Newsdesk","og_description":"Nanobiotix:\u00a0Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021 In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorit\u00e9 des March\u00e9s Financiers (French Financial Markets Authority) PARIS–(BUSINESS WIRE)– Regulatory News: Nanobiotix (Paris:NANO) (NASDAQ:NBTX): Market: Euronext Paris Compartment: B ISIN code: FR0011341205 Website: www.nanobiotix.com Date Number of Shares Outstanding Total number of voting rights Total voting rights, gross (1)\u00a0 Total voting rights, net (2) August 31, 2021 34,825,872 36,019,979 36,010,846 (1) The total number of gross (or \u201ctheoretical\u201d) voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated … Continue reading \"Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-09T20:18:05+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210909006044r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021","datePublished":"2021-09-09T20:18:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/"},"wordCount":472,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210909006044r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/","name":"Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210909006044r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-09-09T20:18:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210909006044r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210909006044r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-statement-of-total-voting-rights-and-shares-forming-the-companys-share-capital-as-of-august-31-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company\u2019s Share Capital as of August 31, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/536670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=536670"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/536670\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=536670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=536670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=536670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}